Neil Roundy, MD
Neurological Surgery · Bend, ORNPI 1174723720
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 60.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $4,829 and has fallen 94.4% since, to $271 in 2025.
Across 49 payments — averaging $202.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$6K
- Centinel Spine, LLC$927
- Surgalign Spine Technologies, Inc.$921
- Alphatec Spine, Inc$592
- Stryker$530
- Boston Scientific$428
- plus $552 from 8 others
Across 13 payments — averaging $2672.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Globus Medical$35K
Across 3 payments — averaging $1,029,000 each. An ownership or investment interest held by the physician or an immediate family member.
- Neuramedica Inc.$3.1M
What the payments were for
- Consulting fees$4,95050%
- Speaking & faculty fees$1,01310%
- Travel & lodging$1,83318%
- Food & beverage$2,12921%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 4 | $5,975 |
| Centinel Spine, LLC | 1 | $927 |
| Surgalign Spine Technologies, Inc. | 9 | $921 |
| Alphatec Spine, Inc | 4 | $592 |
| Stryker | 3 | $530 |
| Boston Scientific | 17 | $428 |
| Medtronic(2 entities) | 3 | $268 |
| Orthofix Medical, Inc. | 1 | $105 |
| Kuros Biosciences USA, Inc | 1 | $55 |
| Cerapedics Inc. | 2 | $31 |
| Abbott | 1 | $30 |
| Nanohive Medical LLC | 1 | $22 |
| Alafair Biosciences, Inc. | 1 | $22 |
| Spineology Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,925 in reported general payments places this provider in the 75th percentile of 95 neurological surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $94 |
| Cyclobenzaprine Hcl | 13 | $79 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Bend
- Mark BelzaBend$9K
- Priscilla PangBend$7K
- Raymond TienBend$1K
- Alp OzpinarSpringfield$235K
- Glenn KeiperEugene$153K
- Josha WoodwardPortland$145K
- Carmina AngelesEugene$97K
- Seth OliveriaPortland$97K
- David Mazur-HartHillsboro$69K
- Daniel ClearyPortland$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.